Abstract
In the United States nearly 600,000 percutaneous coronary interventions (PCI) are performed annually.1 Adjunctive pharmacologic therapies are used to facilitate and assure favorable patient outcomes in the setting of PCI.2, 3, 4 However, complications, some severe, occur with the use of these adjunctive therapies. This chapter will discuss selected complications, including their prevention and treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
